41. NINDS - AIREN Criteria For Vascular Dementia | Internet Stroke Center NINDS AIREN criteria for the diagnosis of vascular dementia. I. Thecriteria for the clinical diagnosis of probable vascular dementia http://www.strokecenter.org/trials/scales/ninds-airen.html

Health Professionals Clinical Trials About Home Trials Directories Complete List Ongoing Trials Acute Stroke Trials Hemorrhage Trials ... Recovery Trials Interventions Drugs - By Name Drugs - By Category Procedures Recovery Therapies Assessment Scales Specific Stroke Scales Stroke Scale Links Stroke Scales Overview Stroke Trial Links Government Sites Independent Sites Meeting Abstracts Recent Abstracts Meetings Calendar Stroke Trial News Current Headlines Trials News Archive General Stroke News About this Site ... Send Feedback Search for Trials By Trial Name By Intervention NINDS - AIREN criteria for the diagnosis of vascular dementia I. The criteria for the clinical diagnosis of

42. DSM IV Criteria For Vascular Dementia | Internet Stroke Center DSMIV criteria for the diagnosis of vascular dementia. A. The developmentof multiple cognitive deficits manifested by both Memory http://www.strokecenter.org/trials/scales/dsm-IV.html

Health Professionals Clinical Trials About Home Trials Directories Complete List Ongoing Trials Acute Stroke Trials Hemorrhage Trials ... Recovery Trials Interventions Drugs - By Name Drugs - By Category Procedures Recovery Therapies Assessment Scales Specific Stroke Scales Stroke Scale Links Stroke Scales Overview Stroke Trial Links Government Sites Independent Sites Meeting Abstracts Recent Abstracts Meetings Calendar Stroke Trial News Current Headlines Trials News Archive General Stroke News About this Site ... Send Feedback Search for Trials By Trial Name By Intervention DSM-IV criteria for the diagnosis of vascular dementia A. The development of multiple cognitive deficits manifested by both:

43. Wileyeurope:: You Have Encountered An Error WileyEurope, vascular dementia Current Concepts by I. Prohovnik (Editor), J. Wade(Editor), S. Knezevic (Editor), T. Tatemichi (Editor), T. Erkinjuntti (Editor http://www.wileyeurope.com/cda/product/0,,047195294X,00.html

MM_preloadImages( "/legacy/include/images/hp_nav_home_on.gif", "/legacy/include/images/hp_nav_browse_on.gif", "/legacy/include/images/hp_nav_offers_on.gif", "/legacy/include/images/hp_nav_about_on.gif", "/legacy/include/images/sb_nav_join_on.gif" ); Shopping Cart My Account Help Contact Us By Keyword By Title By Author By ISBN By ISSN We're Sorry, You Encountered the Following Error: Product page could not be found with isbn 047195294X We apologize for any inconvenience. If you are looking for a specific product, you can enter information in the search box at the top right-hand corner of this page. If you still encounter problems, please contact our webmaster by

44. Vascular Dementia Information And Resources On Helpguide About vascular dementia (MultiInfarct Dementia). Vascular It may bea treatable problem. Details on vascular dementia. Characteristics http://www.helpguide.org/elder/vascular.htm

45. Rationale For Treating Vascular Dementia With Galantamine The pharmacological rationale for treating vascular dementia with galantamine Maelicke,A Institute of Physiological Chemistry and Pathobiochemistry, Johannes http://www.galantamine.cc/research/galantamine-research-18.htm

The pharmacological rationale for treating vascular dementia with galantamine Maelicke, A Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University Medical School, Mainz, Germany. Int J Clin Pract Suppl 2001 May;(120):24-8 ABSTRACT There is considerable evidence indicating that, as in Alzheimer's disease, the central cholinergic system is impaired in vascular dementia (VaD). Using lessons learned from Alzheimer's disease research, it has been proposed that enhancement of the cholinergic system is a rational approach to treating the symptoms of VaD. Galantamine's dual mode of action may provide a greater chance of success in treating patients with Alzheimer's disease through enhanced efficacy on the cognitive, functional and behavioural aspects of dementia. Trials are currently underway to see if this broad spectrum of efficacy extends to patients with Alzheimer's disease with cerebrovascular disease ('mixed' dementia) or VaD, as well as other conditions, and the results are eagerly awaited. Vinpocetine Picamilon Idebenone Pyritinol ... www.

46. BehaveNet® Clinical Capsule™: Vascular Dementia detect evidence of vascular lesions. Diagnostic criteria for 290.4xvascular dementia (cautionary statement). A. The development of http://www.behavenet.com/capsules/disorders/vasculardem.htm

BehaveNet DSM-IV: Vascular Dementia When there is evidence that Dementia is caused by cardiovascular disease this diagnosis may apply. Computed imaging studies of the brain, such as CT (computed tomography) and MRI (magnetic resonance imaging), can usually detect evidence of vascular lesions. Diagnostic criteria for 290.4x Vascular Dementia cautionary statement A. The development of multiple cognitive deficits manifested by both memory impairment (impaired ability to learn new information or to recall previously learned information) (2) one (or more) of the following cognitive disturbances: (a) aphasia (language disturbance) (b) apraxia (impaired ability to carry out motor activities despite intact motor function) (c) agnosia (failure to recognize or identify objects despite intact sensory function) (d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting) B. The cognitive deficits in Criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning. C. Focal neurological

47. AAGP Galantamine Effective Long-term In Treating Vascular Increase Maintain Decrease View Results. AAGP Galantamine Effective Longtermin Treating vascular dementia or Alzheimer's Disease By Bonnie Darves http://www.pslgroup.com/dg/22d7a6.htm

48. AAGP Aricept (Donepezil) Improves Cognition/Function In Vascular AAGP Aricept (Donepezil) Improves Cognition/Function in vascular dementiaORLANDO, FL February 26, 2002 Treatment with Aricept® (donepezil http://www.pslgroup.com/dg/214c52.htm

49. Entrez-PubMed Click here to read Lipoprotein profile in older patients with vasculardementia and Alzheimer's disease. Zuliani G, Ble' A, Zanca http://www.biomedcentral.com/pubmed/11806756

PubMed Nucleotide Protein Genome ... Books Search PubMed Protein Nucleotide Structure Genome PMC OMIM Taxonomy Books PopSet ProbeSet 3D Domains UniSTS Domains SNP Journals UniGene NCBI Web Site for Limits Preview/Index History Clipboard ... Text Version Entrez PubMed Overview FAQ Tutorial New/Noteworthy ... E-Utilities PubMed Services Journals Database MeSH Browser Single Citation Matcher Batch Citation Matcher ... Cubby Related Resources Order Documents NLM Gateway TOXNET Consumer Health ... PubMed Central Summary Brief Abstract Citation ASN.1 MEDLINE XML UI List LinkOut Related Articles Domain Links 3D Domain Links Genome Links ProbeSet Links Nucleotide Links OMIM Links PMC Links Cited in PMC PopSet Links Protein Links SNP Links Structure Links Show: Sort Author Journal Pub Date Text File Clipboard Order BMC Geriatr 2001;1(1):5 Related Articles, Links Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. Zuliani G, Ble' A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R. Department of Clinical and Experimental Medicine, Section of Internal Medicine II, University of Ferrara, Italy. gzuliani@hotmail.com PMID: 11806756 [PubMed - as supplied by publisher] Summary Brief Abstract Citation ASN.1

50. BioMed Central | Full Text | Lipoprotein Profile In Older Patients With Vascular Lipoprotein profile in older patients with vascular dementia and Alzheimer's diseaseGiovanni Zuliani 1 , 2 , Alessandro Ble' 1 , Rosanna Zanca 1 , Maria Rosa http://www.biomedcentral.com/1471-2318/1/5

Welcome guest user home journals A-Z journals by subject advanced search ... Volume 1 Viewing options Abstract Full text PDF Pre-publication history Other links: E-mail to a friend Download references Post a comment PubMed record ... Related articles in PubMed Search PubMed For Zuliani G Ble' A Zanca R Munari MR ... Fellin R Key E-mail Corresponding author Research article Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease Giovanni Zuliani Alessandro Ble' Rosanna Zanca Maria Rosa Munari Amedeo Zurlo Chella Vavalle Anna Rita Atti and Renato Fellin Department of Clinical and Experimental Medicine, Section of Internal Medicine II, University of Ferrara, Italy Centro Esperto Malattia di Alzheimer-Perusini, Ferrara, Italy Long Term Division, Ca' Foncello Hospital, Treviso, Italy Geriatric Division, S. Anna Hospital, Ferrara, Italy BMC Geriatrics The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2318/1/5 Received Accepted Published Outline Abstract Abstract Background Materials and methods Results ... References Background Some alterations of the lipoprotein profile have been associated with cerebrovascular disease. Recently, it has been suggested that cerebrovascular disease might play a role in the pathogenesis of both vascular dementia (VD) and Alzheimer's disease (AD). Nevertheless, the possible association of dyslipidemias with VD or AD is still a controversial issue.

51. Vascular Dementia vascular dementia typically has a fluctuating course with periods of improvementand stepwise deterioration. vascular dementia; Great brain images from Harvard. http://www.siumed.edu/lib/ref/StudentPages/Obrien/vascular.html

52. Vascular Dementia vascular dementia. Search Our Site. MedQuest Home. vascular dementia Treatingvascular dementia With Ginkgo Biloba* What is vascular dementia? http://www.mqrx.com/gateway/vd.html

Vascular Dementia Search Our Site Vascular Dementia Treating Vascular Dementia With Ginkgo Biloba* What is Vascular Dementia? Dementia is loss of cognitive and emotional abilities severe enough to interfere with daily functioning and the quality of life. Vascular dementia is dementia that results from insufficient blood flow to the brain, called cerebral insufficiency. Vascular dementia is the second leading cause of dementia, just below Alzheimer's disease. There is a strong body of evidence that Ginkgo Biloba helps alleviate cerebral insufficiency by increasing the blood flow to the brain. This would tend to have a positive influence on vascular dementia. Ginkgo Biloba Clinical Proof A massive body of scientific evidence supports a variety of medicinal uses of Ginkgo Biloba. In fact, the European medical community has recognized Ginkgo Biloba as an effective compound in the treatment of cerebral insufficiency (poor blood flow to the brain) resulting in vascular dementia. Recent studies in which Ginkgo Biloba demonstrated therapeutic effects in the treatment of dementia have even earned Ginkgo Biloba the approval of the German BGA for use in the treatment of dementia, as well as memory deficits, impaired concentration, depression, dizziness, tinnitus (ringing in the ears) and headache; particularly when these are due to cerebral insufficiency. A study compiling the results of using Gingko Biloba to treat 202 patient's diagnosed with Alzheimer's disease or dementia came to the conclusion that Gingko Biloba was "safe and appears capable of stabilizing and, in a substantial number of cases, improving the cognitive performance and the social functioning of demented patients for 6 months to 1 year."

53. OUP: Vascular Cognitive Impairment: Bowler . vascular dementia, caused by multiple small strokes, isthe second commonest cause of dementia behind Alzheimer's disease....... http://www.oup.co.uk/isbn/0-19-263267-1

VIEW BASKET Quick Links About OUP Career Opportunities Contacts Need help? oup.com Search the Catalogue Site Index American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Journals Law Medicine Music Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences World's Classics UK and Europe Book Catalogue Help with online ordering How to order Postage Returns policy ... Table of contents Vascular Cognitive Impairment - Preventable Dementia Edited by John Bowler , Department of Neurology, Royal Free Hospital, London, UK, and Vladimir Hachinski , Department of Clinical Neurological Sciences, London Health Sciences Centre, University of Western Ontario, London, Canada Publication date: 22 April 2003 368 pages, 17 line drawings and 6 halftones and a colour plate section, 240mm x 168mm Ordering Individual customers may: order by phone, post, or fax

54. Vascular Dementia Information Center | Internet Stroke Center his site provides information about vascular dementia. vascular dementia isthe second most common cause of dementia, after Alzheimer's Disease. http://www.vascular-dementia.info/

Health Professionals Clinical Trials About Home Vascular Dementia Resources for Patients and Families Resources for Health Professionals Search Search the ISC Search the Web his site provides information about vascular dementia. Vascular dementia is a term for memory loss and cognitive impairment associated with strokes and cerebrovascular disease. Related names for this condition include multi-infarct dementia, stroke-related dementia, and Binswanger's Disease. Vascular dementia is the second most common cause of dementia, after Alzheimer's Disease. !This page is under construction! Vascular Dementia Resources for Patients and Families MEDLINEplus Medical Encyclopedia: Multi-infarct dementia Helpful information from the National Institutes of Health NINDS Multi-Infarct Dementia Information Page National Institute of Neurological Disorders and Stroke, NIH

55. Aricept Efficacious For Vascular Dementia Aricept Efficacious for vascular dementia Data presented Wednesday at the AmericanAcademy of Neurology (AAN) Annual Meeting showed that Pfizer (NYSE PFE) and http://www.bioportfolio.com/news/btech_041802_3.htm

BioWeb: Advanced BioNews: Advanced Have your news published using BioPortfolio's BioNewsCast service - view details! Aricept Efficacious for Vascular Dementia Data presented Wednesday at the American Academy of Neurology (AAN) Annual Meeting showed that Pfizer (NYSE: PFE) and Eisai's Aricept (donepezil hydrochloride tablets) was both efficacious and well tolerated in patients with vascular dementia. The results are a significant step towards increased use and label expansion. The study reproduced observations from earlier investigation, solidifying their resultant conclusions. The cognitive decline in vascular dementia, characterized by confusion, memory loss, impaired orientation, and impaired judgment, is initiated by a stroke or series of strokes, and is second only to Alzheimer disease (AD) as a cause of dementia. This confirmatory randomized, double-blind, placebo-controlled, 24-week trial evaluated 603 patients with vascular dementia without a prior AD diagnosis. Study subjects received high or low dose Aricept or placebo daily, and were assessed with various well-verified tools used in the clinical evaluation of cognitive decline. High and low dose Aricept recipients achieved statistically significant advantages in terms of cognitive function as measured by the Alzheimer's Disease Assessment Scale (ADAS-cog), cognitive function as measured by the Mini-Mental State Examination (MMSE), and slowing of functional deterioration as measured by the Alzheimer's Disease Functional Assessment and Change Scale (ADFACS).

56. Feb 03 Stroke & Vascular Dementia feb03cover2.jpg (343122 bytes), Click on this image to be taken tothe February 2003 issue 'Stroke and vascular dementia'. Click http://signpostjournal.connect-2.co.uk/feb2003.htm

Signpost is the national, non-profit making subscription journal produced by the Practice Development Unit (MHSOP) of Cardiff and Vale NHS Trust in association with the Dementia Services Development Centre Wales. Its mission statement is: "Working together towards a better service and improved quality of life for people with dementia, older people with mental health problems, and their carers" *** New Feb 2003 page installed *** Please note new address and charges Click on this image to be taken to the February 2003 issue - 'Stroke and Vascular Dementia' Click on this image to vote for this web-site as a Top 100 Alzheimer's/ Caregivers site Search WWW Search signpostjournal.connect-2.co.uk Click below to sign the Signpost Guest Book and share your experiences/suggestions. And let us know what you think of the web-site View Signpost Guestbook Sign Signpost Guestbook A message from the Editor Welcome to the February 2003 issue page. I hope you like this new format. It seemed like time for a change and from now on the Editorial and a sample article will be included as Acrobat Adobe PDF files. I'm afraid if you want the News updates you will have to subscribe. Please let me know what you think..... Regards, Simon Click on the links to see the articles, and if you have not yet installed the Acrobat Reader you can download this free of charge by clicking on the symbol below and following the instructions on the Acrobat Adobe web-site.

57. VASCULAR DEMENTIA vascular dementia. vascular dementia (VD) is generally accepted as the second mostcommon cause of dementia, only outnumbered by Alzheimer´s disease (AD). http://www.neuroacta.cz/4/vasculardementia.html

VASCULAR DEMENTIA Department of Neurology, 3 rd Medical Faculty, Charles University, Prague, Czech Republic Besides general history clinical diagnosis of dementia is based on a cognitive evaluation, a behavioural assessment and a neurological examination: 1. In all patients, a short mental status test should be part of the clinical examination. The level of intellectual performance such as memory, language, praxis, visuospacial function, temporal orientation, executive functions can be measured by several tools, Mini-Metal Scale Examination (MMSE) of which is most widely used. This test is a simple screening and easy to administer in ten minutes. A cognitive decline can be roughly quantified in the range from to 30 points. It is relatively insensitive to mild deficits and is influenced by education and age. A variety of vascular pathologies are related to VD syndrome. Large-vessel arteriopathies can lead to single or multiple infarcts, whereas small-vessel arteriopathies are the cause of subcortical infarcts. Other factors associated with VD are diffuse white matter lesions, cardiac embolic strokes, hemodynamic changes, hemorrhages and hematology abnormalities. The association between the type, extent, side, site, and tempo of vascular lesions in the brain and different types of vascular cognitive impairment has not been clearly established. Studies on VaD, which have been based on the multiinfarct concept, indicate that bilateral ishemic lesions have a significant role. The locations that are most important are not known precisly.

58. Vascular Dementia&&Dementia Care&&Caregiver Burden vascular dementia (Dementia Care, Alzheimer Disease, Aricept) url www.alzheimercentre.ca. VascularDementia Canadian Alzheimer's Disease Centre http://www.searchaword.net/Vascular_Dementia/

Vascular Dementia Dementia Care Caregiver Burden Loss Memory ... Aricept Vascular Dementia : Canadian Alzheimer's Disease Centre Researchers are also investigating whether these drugs may be used in more severe cases of Alzheimer's disease and whether they may be used in other types of dementia such as Lewy body and vascular dementia

59. Vascular Dementia (European Definition) F01 vascular dementia. (Multiinfact Dementia) Vascular (formerly arteriosclerotic suggestingAlzheimer's disease. F01.1 vascular dementia Of Acute Onset. http://www.traumasurvival.org/~medicaid/dis-eur/dis-cogn-mult.htm

60. Lars A. Carlson Vascular Dementia Lars A. Carlson vascular dementia. vascular dementia Carlson Lars A. Gottfries CarlG. Winblad Bengt Psychotherapy and Psychos Diagnostic Oncology, Vol . http://www.literatur-zentrale.de/Vascular-Dementia-3805559844.html

Lars A. Carlson Vascular Dementia Vascular Dementia Carlson Lars A. Gottfries Carl G. Winblad Bengt Phonetica, geb., Vol.51/1... Phonetica, kt., Vol.51/1-... Magnetresonanztomographie... In Memoriam Professor Dr.... ... Home

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 93    Back | 1  | 2  | 3  | 4  | 5  | Next 20